Theraclone Sciences, Inc. — Form D/A
Theraclone Sciences, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2013-07-29. The offering totals $6.4M, of which $6.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-07-29
- Form: D/A
- Accession: 0001310967-13-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $6.4M
- Amount sold: $6.0M
- Remaining: $396K
- Investors: 2
- Date of first sale: 2013-03-11
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-200360
Issuer
- Name: Theraclone Sciences, Inc.
- CIK: 0001310967
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1124 COLUMBIA ST, SEATTLE, WA, 98104
- Phone: 206-805-1617
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Eleanor Ramos | Executive Officer | Seattle, WA |
| Steven Gillis | Director | South San Francisco, CA |
| Steven Gillis | Executive Officer | South San Francisco, CA |
| Wende Hutton | Director | Menlo Park, CA |
| Clifford Stocks | Director | Houston, TX |
| Clifford Stocks | Executive Officer | Houston, TX |
| William Greene | Director | South San Francisco, CA |
| Christopher Mirabelli | Director | Cambridge, MA |
| Russ Hawkinson | Executive Officer | Seattle, WA |
| Wendye Robbins | Director | SOUTH SAN FRANCISCO, CA |
| Kristine Swiderek | Executive Officer | Seattle, WA |
| Teri Koller | Executive Officer | Seattle, WA |
| Witold Cieplak | Executive Officer | Seattle, WA |
| David Fanning | Director | Seattle, WA |
| David Fanning | Executive Officer | Seattle, WA |
Other filings by this issuer (6)
More